NASDAQ:SMMT
Summit Therapeutics Inc.
- Stock
Last Close
12.86
30/08 20:00
Market Cap
5.82B
Beta: −1.02
Volume Today
2.05M
Avg: 2.06M
PE Ratio
−1.63
PFCF: −51.96
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jan '14 | Jan '15 | Jan '16 | Jan '17 | Jan '18 | Jan '19 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 204.39K - | 2.32M 1,037.53% | 2.36M 1.64% | 336.83K 85.75% | 55.28K 83.59% | -5.86M - | -2.27M 61.15% | 154.33M 6,885.34% | 151.97M 1.53% | |||
average payables | 2.61M - | 4.33M 65.66% | 5.09M 17.45% | 4.77M 6.16% | 8.81M 84.61% | 12.13M 37.72% | 5.81M 52.09% | 3.07M 47.19% | 5.26M 71.24% | 2.36M 55.02% | 1.51M 36.10% | |
average receivables | 917.69K - | 1.05M 14.71% | 1.73M 64.76% | 3.51M 102.32% | 2.37M 32.50% | 5.09M - | 13.67M 168.44% | 11.64M 14.89% | 3.48M 70.08% | |||
book value per share | 1.63 - | 0.57 65.00% | 0.51 10.57% | -0.07 113.93% | 0.21 401.14% | 0.65 204.78% | 1.14 - | 0.63 44.67% | 0.66 3.60% | 0.00 99.98% | ||
capex per share | -0.02 - | -0.00 91.71% | -0.00 19.43% | -0.00 12.37% | -0.01 479.80% | -0.00 81.54% | -0.01 - | -0.00 61.63% | -0.00 38.93% | -0.00 99.99% | ||
capex to depreciation | -1.81 - | -1.06 41.33% | -1.38 29.64% | -1.52 10.34% | -1.95 28.34% | -0.11 94.36% | -0.08 26.45% | -0.21 160.17% | -0.12 40.70% | -0.25 99.14% | -0.06 74.84% | |
capex to operating cash flow | 0.01 - | 0.00 61.41% | 0.00 24.29% | -0.01 288.69% | 0.03 549.90% | 0.00 85.69% | 0.00 4.33% | 0.01 96.06% | 0.00 51.82% | 0.02 255.97% | 0.00 88.89% | |
capex to revenue | -0.03 - | -0.02 31.98% | -0.04 - | -0.02 50.66% | -0.00 84.58% | -0.00 4.80% | -0.49 17,594.01% | -0.17 65.45% | -0.89 423.78% | |||
cash per share | 0.69 - | 0.43 38.20% | 0.39 8.34% | 0.57 45.05% | 0.43 23.70% | 0.41 5.48% | 0.96 - | 0.55 42.94% | 1.80 230.82% | 0.00 99.98% | ||
days of inventory on hand | ||||||||||||
days payables outstanding | 47.25K - | 170.30K 260.43% | ||||||||||
days sales outstanding | 147.68 - | 191.13 29.42% | 600.36 - | 4.32K - | 3.46K 19.92% | 3.17K 8.46% | ||||||
debt to assets | -0.18 - | 0.45 - | 0.02 94.83% | 0.11 355.68% | -0.04 138.65% | 0.00 111.03% | 0.02 440.89% | 0.78 3,083.08% | 0.52 33.07% | |||
debt to equity | -0.25 - | -4.86 - | 0.13 102.63% | 0.15 17.15% | -0.02 115.81% | 0.01 124.77% | 0.03 470.76% | 4.10 12,161.81% | 1.37 66.66% | |||
dividend yield | ||||||||||||
earnings yield | -0.34 - | -0.06 81.02% | -0.06 0.45% | -0.05 18.32% | -0.02 69.48% | 0.11 807.47% | -0.16 - | -0.24 50.77% | -0.09 62.77% | -0.00 99.58% | ||
enterprise value | 26.47M - | 250.63M 846.87% | 355.45M 41.82% | 473.78M 33.29% | 601.60M 26.98% | 51.88M 91.38% | -27.86M 153.71% | 260.81M 1,036.05% | 285.30M 9.39% | 991.83M 247.64% | 1.62T 162,962.65% | |
enterprise value over ebitda | -2.40 - | -12.93 438.70% | -11.81 8.68% | -15.29 29.46% | -44.82 193.09% | 3.74 108.34% | -1.84 149.17% | -5.07 175.61% | -3.31 34.67% | -16.31 392.77% | 1.62M 9,904,893.29% | |
ev to operating cash flow | -2.73 - | -14.69 437.21% | -14.53 1.10% | 31.22 314.93% | -28.93 192.68% | -1.48 94.90% | 1.05 170.79% | -5.42 618.76% | -3.93 27.50% | -23.85 506.86% | -21.07K 88,233.39% | |
ev to sales | 11.67 - | 110.50 846.87% | 164.51 - | 16.72 89.84% | 0.92 94.50% | -0.65 170.44% | 303.27 46,915.54% | 157.71 48.00% | 1.41K 792.93% | |||
free cash flow per share | -2.02 - | -0.43 78.62% | -0.42 3.84% | 0.24 158.89% | -0.33 234.05% | -0.41 25.56% | -0.70 - | -0.55 20.72% | -0.22 60.55% | -0.00 99.94% | ||
free cash flow yield | -0.33 - | -0.06 80.46% | -0.06 1.42% | 0.03 145.64% | -0.03 215.09% | -0.41 1,089.54% | -0.15 - | -0.21 38.52% | -0.05 75.03% | -0.00 99.91% | ||
graham net net | 0.25 - | 0.34 35.13% | 0.33 1.06% | -0.21 162.05% | -0.52 152.17% | 0.15 128.41% | 0.65 - | 0.44 32.03% | -0.17 139.33% | 0.00 100.06% | ||
graham number | 8.73 - | 2.35 73.04% | 2.17 7.71% | 0.83 61.68% | 0.86 3.46% | 1.30 50.86% | 4.41 - | 3.05 30.90% | 2.38 21.93% | 0.00 99.93% | ||
income quality | 0.88 - | 0.89 2.12% | 0.85 4.66% | -0.47 155.38% | 1.35 385.52% | -5.33 494.96% | 0.91 - | 0.82 10.27% | 0.53 35.57% | 0.12 76.35% | ||
intangibles to total assets | 0.53 - | 0.21 59.41% | 0.16 22.84% | 0.11 33.33% | 0.32 190.87% | 0.21 35.05% | 0.51 144.56% | 0.13 73.99% | 0.11 17.18% | 0.00 97.53% | 0.01 244.55% | |
interest coverage | -6.99 - | 1.29K 18,549.53% | 81.85 93.66% | -28.83 135.22% | -11.08 61.58% | 22.26 300.99% | -208.60 - | -306.71 47.03% | -16.38 94.66% | |||
interest debt per share | -0.08 - | -0.00 99.55% | -0.01 1,484.40% | 0.36 6,195.64% | 0.05 85.52% | 0.10 97.97% | 0.01 - | 0.02 124.55% | 2.71 11,536.19% | 0.00 99.99% | ||
inventory turnover | ||||||||||||
invested capital | -0.25 - | -4.86 - | 0.13 102.63% | 0.15 17.15% | -0.02 115.81% | 0.01 124.77% | 0.03 470.76% | 4.10 12,161.81% | 1.37 66.66% | |||
market cap | 29.82M - | 267.60M 797.46% | 378.67M 41.51% | 508.85M 34.38% | 630.05M 23.82% | 87.10M 86.18% | 326.76M - | 354.31M 8.43% | 821.68M 131.91% | 1.62T 196,726.01% | ||
net current asset value | 2.02M - | 16.22M 701.97% | 24.09M 48.52% | -9.68M 140.18% | -11.60M 19.88% | 38.70M 433.56% | 44.96M 16.16% | 43.37M 3.52% | 67.22M 54.99% | 119.20M 77.32% | 64.45M 45.93% | |
net debt to ebitda | 0.30 - | 0.88 188.38% | 0.77 11.91% | 1.13 46.72% | 2.12 87.24% | -2.54 219.78% | -1.84 27.59% | 1.28 169.69% | 0.80 37.51% | -2.80 449.50% | 34.64 1,337.79% | |
net income per share | -2.08 - | -0.43 79.23% | -0.41 4.76% | -0.43 5.40% | -0.15 64.46% | 0.12 174.67% | -0.76 - | -0.65 13.71% | -0.38 41.18% | -0.00 99.74% | ||
operating cash flow per share | -2.01 - | -0.43 78.51% | -0.41 3.91% | 0.25 159.55% | -0.32 228.87% | -0.41 29.05% | -0.69 - | -0.55 20.36% | -0.22 60.97% | -0.00 99.94% | ||
payables turnover | 0.01 - | 0.00 72.26% | ||||||||||
receivables turnover | 2.47 - | 1.91 22.73% | 0.61 - | 0.08 - | 0.11 24.88% | 0.12 9.25% | ||||||
research and ddevelopement to revenue | 4.77 - | 6.89 44.40% | 8.23 - | 1.14 86.14% | 0.91 20.09% | -0.91 200.02% | 61.95 6,900.17% | 47.18 23.83% | 73.83 56.48% | |||
return on tangible assets | -1.94 - | -0.75 61.62% | -0.82 9.52% | -0.64 21.72% | -0.19 69.58% | 0.16 181.81% | 0.42 161.33% | -0.59 242.60% | -0.85 44.03% | -0.11 86.84% | -3.06 2,623.62% | |
revenue per share | 0.47 - | 0.06 87.81% | 0.05 - | 0.55 1,075.17% | 0.66 19.71% | 0.01 - | 0.01 11.03% | 0.00 73.48% | ||||
roe | -1.28 - | -0.76 40.66% | -0.81 6.50% | 6.12 856.65% | -0.72 111.80% | 0.18 124.50% | 0.12 33.64% | -0.66 664.93% | -1.03 55.96% | -0.59 43.22% | -7.91 1,247.74% | |
roic | -1.71 - | -0.76 55.51% | -0.81 6.23% | -1.53 89.36% | -0.76 50.56% | 0.29 138.10% | 0.37 29.48% | -0.66 276.24% | -0.94 43.10% | -0.10 88.90% | 0.01 105.03% | |
sales general and administrative to revenue | 1.43 - | 3.00 109.86% | 3.59 - | 0.47 86.86% | 0.29 39.21% | 22.36 - | 13.05 41.64% | 37.91 190.46% | ||||
shareholders equity per share | 1.63 - | 0.57 65.00% | 0.51 10.57% | -0.07 113.93% | 0.21 401.14% | 0.65 204.78% | 1.14 - | 0.63 44.67% | 0.66 3.60% | 0.00 99.98% | ||
stock based compensation to revenue | 0.16 - | 0.64 288.41% | 0.60 - | 0.06 89.44% | 0.11 74.42% | 2.05 - | 7.08 244.68% | 16.96 139.68% | ||||
tangible asset value | 2.09M - | 16.30M 678.75% | 24.21M 48.49% | -9.53M 139.38% | -10.46M 9.69% | 39.51M 477.81% | 30.12M 23.77% | 65.91M 118.83% | 70.88M 7.54% | 124.86M 76.16% | 75.80M 39.29% | |
tangible book value per share | 0.43 - | 0.41 5.06% | 0.41 0.51% | -0.15 137.82% | -0.16 3.18% | 0.46 388.46% | 0.95 - | 0.54 43.24% | 0.65 20.01% | 0.00 99.98% | ||
working capital | 2.02M - | 17.22M 751.44% | 25.14M 45.99% | 28.05M 11.59% | 23.99M 14.49% | 44.42M 85.17% | 28.69M 35.40% | 46.53M 62.15% | 71.69M 54.08% | 617.93M 761.96% | 169.31M 72.60% |
All numbers in USD (except ratios and percentages)